About Doutor ao Vivo
Doutor ao Vivo is a Healthcare company based in Sao Paulo (Brazil) founded in 2019 by Mauren Ginaldo Souza and Luciano Lima. White-label telemedicine platform is provided for healthcare companies. Doutor ao Vivo has raised $329.68 thousand across 1 funding round from investors including Sebrae, Bossa Invest and Raja Ventures. Its chief executive, as recorded, is Mauren Ginaldo Souza. Doutor ao Vivo offers products and services including Plataforma de Telemedicina, Equipe Médica, Totem de Telemedicina, and Aplicativo. Its focus areas include HealthTech, Healthcare IT, Provider and Telemedicine Solutions. Its competitors include SulAmrica - Todos os direitos reservados, Unimed Campinas and Kompa; 1 of its 3 listed competitors has raised funding.
Company details
A white-label telemedicine platform was established in 2019 in Sao Paulo, Brazil, to support healthcare companies. Telemedicine practices are enabled for doctors via videoconferencing in modalities including teleconsultation, tele guidance, tele interconsultation, and teletriage. Solutions are delivered across sectors such as institutions, healthcare operators, corporate entities, health cards, and public health systems.
- Headquarters Sao Paulo, Brazil
- Founders Mauren Ginaldo Souza, Luciano Lima
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website doutoraovivo.com.br
- Social LinkedIn Facebook Instagram
- Total Equity Funding$329.68K (USD)
in 1 rounds
- Latest Funding Round$329.68K (USD), Seed
Apr 2024
- InvestorsSebrae
& 4 more
Products & Services of Doutor ao Vivo
Doutor ao Vivo offers a comprehensive portfolio of products and services, including Plataforma de Telemedicina, Equipe Médica, Totem de Telemedicina, and Aplicativo.
Platform for virtual medical consultations and patient management.
Team providing remote health support and consultations.
Device for in-person telemedicine interactions.
App for scheduling and accessing health services remotely.
Funding Insights of Doutor ao Vivo
Doutor ao Vivo has successfully raised a total of $329.68K through 1 strategic funding round. The most recent funding activity was a Seed round of $329.68 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $329,683
- Total Rounds 1
- Last Round Seed — $329,683
- First Round $329,683
(Apr 2024)
- Investors Count 5
All 1 funding rounds of Doutor ao Vivo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $329,683 | Seed | – | – |
5 investors in total: 5 institutional.
Investors in Doutor ao Vivo
Doutor ao Vivo has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Sebrae, Bossa Invest and Raja Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are managed by Bossa Invest in Brazil. | bossainvest.com | Sao Paulo, Brazil | ||
| rajaventures.com | ||||
| fcjangels.com | ||||
| priviticapital.com | ||||
Management consulting services are provided by this non-profit to businesses. | 1972 | sebrae.com.br | Sao Paulo, Brazil |
Investor details for Doutor ao Vivo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Doutor ao Vivo
2 people are tracked at Doutor ao Vivo (2 in leadership).
| Name | Role | Group |
|---|---|---|
Mauren Ginaldo Souza | Co-Founder & CEO | Leadership |
Luciano Lima | Co-Founder | Leadership |
Complete people profiles for Doutor ao Vivo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Doutor ao Vivo
2 dated milestones of Doutor ao Vivo across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Doutor ao Vivo is founded.
- Funding First funding round of $330K.
Competitors of Doutor ao Vivo
Doutor ao Vivo has 3 listed competitors in our database, 1 of them funded. They include SulAmrica - Todos os direitos reservados, Unimed Campinas and Kompa.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sulamericadiretobrasilia.com.br | 1966 | Sao Paulo, Brazil | A digital platform networks patients and hospitals for professionals. | |||
| unimedcampinas.com.br | 1971 | Campinas, Brazil | Offers health insurance plans via app for individuals and companies. | |||
| kompa.com.br | 2019 | Sao Paulo, Brazil | $1.42M | Provider of online remote consultation services with the healthcare providers |
Detailed competitors of Doutor ao Vivo
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Doutor ao Vivo
The website of Doutor ao Vivo (doutoraovivo.com.br) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 30% vs previous month
Websites whose visitors overlap most with Doutor ao Vivo. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
docway.com.br | docway.com.br | 100% | #295,389 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Doutor Ao Vivo
Complete news archive for Doutor ao Vivo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Doutor ao Vivo
Doutor ao Vivo was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Doutor ao Vivo is headquartered in Sao Paulo, Brazil.
Mauren Ginaldo Souza is the CEO of Doutor ao Vivo, as recorded in our data. They have also founded this company.
Doutor ao Vivo is a funded company, having raised a total of $329.68K across 1 funding round to date. The company's 1st funding round was a Seed of $329.68K, raised on Apr 2024.
A white-label telemedicine platform was established in 2019 in Sao Paulo, Brazil, to support healthcare companies. Telemedicine practices are enabled for doctors via videoconferencing in modalities including teleconsultation, tele guidance, tele interconsultation, and teletriage. Solutions are delivered across sectors such as institutions, healthcare operators, corporate entities, health cards, and public health systems.
Doutor ao Vivo's top competitors include SulAmrica - Todos os direitos reservados, Kompa and Unimed Campinas.
Doutor ao Vivo offers Plataforma de Telemedicina, Equipe Médica, Totem de Telemedicina, and Aplicativo.
Doutor ao Vivo has 5 investors. Key investors include Sebrae, Bossa Invest, Raja Ventures, FCJ, and Priviti Capital.